234 related articles for article (PubMed ID: 20467341)
1. Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition.
Zhao H; Guan J; Lee HM; Sui Y; He L; Siu JJ; Tse PP; Tong PC; Lai FM; Chan JC
Pancreas; 2010 Aug; 39(6):843-6. PubMed ID: 20467341
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
3. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
[TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors.
Hou X; Ling Z; Quartier E; Foriers A; Schuit F; Pipeleers D; Van Schravendijk C
Diabetologia; 1999 Feb; 42(2):188-94. PubMed ID: 10064099
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes.
Westermark GT; Westermark P
Exp Diabetes Res; 2008; 2008():429274. PubMed ID: 18825272
[TBL] [Abstract][Full Text] [Related]
6. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
7. Metabolic stress, IAPP and islet amyloid.
Montane J; Klimek-Abercrombie A; Potter KJ; Westwell-Roper C; Bruce Verchere C
Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():68-77. PubMed ID: 22928566
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling of human islets from individuals with and without type 2 diabetes: promises and pitfalls.
Locke JM; Harries LW
Biochem Soc Trans; 2012 Aug; 40(4):800-3. PubMed ID: 22817737
[TBL] [Abstract][Full Text] [Related]
9. Role of islet amyloid in type 2 diabetes mellitus.
Höppener JW; Lips CJ
Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
[TBL] [Abstract][Full Text] [Related]
10. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
Iki K; Pour PM
J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
[TBL] [Abstract][Full Text] [Related]
11. Amyloid oligomers in diabetic and nondiabetic human pancreas.
Zhao HL; Sui Y; Guan J; He L; Gu XM; Wong HK; Baum L; Lai FM; Tong PC; Chan JC
Transl Res; 2009 Jan; 153(1):24-32. PubMed ID: 19100955
[TBL] [Abstract][Full Text] [Related]
12. Higher islet amyloid load in men than in women with type 2 diabetes mellitus.
Zhao HL; Sui Y; Guan J; He L; Lai FM; Zhong DR; Yang D; Baum L; Tong PC; Tomlinson B; Chan JC
Pancreas; 2008 Oct; 37(3):e68-73. PubMed ID: 18815541
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus.
Hayden MR; Karuparthi PR; Manrique CM; Lastra G; Habibi J; Sowers JR
Exp Biol Med (Maywood); 2007 Jun; 232(6):772-9. PubMed ID: 17526769
[TBL] [Abstract][Full Text] [Related]
14. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
[TBL] [Abstract][Full Text] [Related]
15. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
Hull RL; Westermark GT; Westermark P; Kahn SE
J Clin Endocrinol Metab; 2004 Aug; 89(8):3629-43. PubMed ID: 15292279
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
Matveyenko AV; Butler PC
Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
de Koning EJ; Fleming KA; Gray DW; Clark A
J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
[TBL] [Abstract][Full Text] [Related]
20. Expansion and redifferentiation of adult human pancreatic islet cells.
Ouziel-Yahalom L; Zalzman M; Anker-Kitai L; Knoller S; Bar Y; Glandt M; Herold K; Efrat S
Biochem Biophys Res Commun; 2006 Mar; 341(2):291-8. PubMed ID: 16446152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
